Related Experiment Videos

Postmortem stability of dopamine D1 receptor mRNA and D1 receptors

J H Gilmore1, C P Lawler, A M Eaton

  • 1Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599-7160.

Insights

Postmortem interval has minimal impact on dopamine D1 mRNA levels in rat brains. However, dopamine D1 receptors show a slight decrease within the first 6 hours postmortem.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The postmortem interval (PMI) can affect the stability of RNA and proteins in brain tissue.
  • Understanding PMI effects is crucial for interpreting molecular findings in postmortem human brains, especially in neuropsychiatric research.

Purpose of the Study:

  • To investigate the impact of simulated postmortem handling on dopamine D1 mRNA and D1 receptor levels in rat striatum.
  • To determine if PMI affects the reliability of measuring dopamine D1 system components in postmortem brain samples.

Main Methods:

  • Assessed dopamine D1 mRNA using in situ hybridization with radiolabeled oligonucleotide probes.
  • Quantified D1 receptor density via autoradiography with a specific radioligand ([125I]SCH 23982).
  • Examined tissue at postmortem intervals of 0, 6, 12, and 24 hours.

Main Results:

  • Dopamine D1 mRNA levels and the distribution of cells expressing D1 mRNA remained stable across all postmortem intervals.
  • A significant, modest decrease (approximately 10%) in D1 receptor density was observed within the first 6 hours postmortem.
  • No further significant changes in D1 receptor density occurred between 6 and 24 hours postmortem.

Conclusions:

  • The postmortem interval has a limited effect on dopamine D1 mRNA integrity in rat striatum.
  • Dopamine D1 receptor levels are relatively stable beyond 6 hours postmortem, suggesting minimal impact on studies using tissue within this timeframe.
  • These findings support the utility of postmortem brain tissue for investigating alterations in the dopamine D1 system in neuropsychiatric disorders.

Related Concept Videos